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Introduction. PU is an option to manage complex and/or recurrent urethral strictures and is necessary after urethrectomy and/or
penectomy. PU is generally assumed to be the last option before abandoning the urethral outlet.Methods. Between 2001 and 2013,
51 patients underwent PU. Mean age (± standard deviation) was 60 ± 15 years. Only 13 patients (25.5%) did not undergo previous
urethral interventions. PUwas performed according to the Johanson (𝑛 = 35) or Blandy (𝑛 = 16) technique and these 2 groups were
compared for surgical failure, maximum urinary flow (Qmax), urinary symptoms, and quality of life (according to the International
Prostate Symptom Score). Results. Both groups were similar for patient’s and stricture characteristics. Only follow-up duration
was significantly longer after Johanson PU (47.9 months versus 11.1 months; 𝑃 = 0.003). For the entire cohort, 11 patients (21.6%)
were considered a failure (9 or 25.7% for Johanson group and 2 or 12.5% for Blandy group; 𝑃 = 0.248). There was a significant
improvement of Qmax in both groups. Quality of life after PU was comparable in both groups. Conclusions. PU is associated with a
21.6% recurrence rate and the patient should be informed about this risk.
1. Introduction
Urethroplasty is the best option to restore urethral patency
in case of urethral stricture disease [1, 2]. Nevertheless,
urethroplasty is associated with a failure rate of 10–50%,
depending on stricture etiology, stricture length, previous
interventions, and the type of technique used [3–6]. Stricture
recurrence after (several attempts of) urethroplasty might
trigger the decision to stop further attempts in restoring
patency of the entire urethra. The surgeon might take this
decision because he has no further reconstructive options
left or the patient might take this decision because he does
not want further reconstruction with the risk of recurrent
stricture [7]. At that point, perineal urethrostomy (PU) is a
valuable option. A successful PU allows the patient to resume
normal voiding and is generally assumed to be the last option
before abandoning the urethral outlet. This procedure is
reported to be a satisfactory solution, especially in the elderly
[7]. PU is also needed after urethrectomy and/or penectomy
[8, 9]. Different types of PU have been described [7, 10–12].
These techniques are mainly derived from the first stage of
the two-stage urethroplasty described by Johanson [13] and
Blandy et al. [14], both renowned pioneers in the field of
urethral surgery.
The aim of this paper is to evaluate the surgical and
functional outcome after Johanson or Blandy PU. To our
knowledge, this is the largest series published on Johanson
PU and the first to compare Johanson with Blandy PU.
2. Material and Methods
2.1. Patient Population. Fifty-one patients underwent PU at
the Ghent University Hospital between January, 2001, and
June, 2013 (Table 1). Datawere retrospectively analysed.Mean
(± standard deviation) and median (interquartile range)
follow-up of the entire cohort was, respectively, 36 (± 41.6)
and 16 (8–48) months. The Johanson and Blandy technique
was used in 35 and 16 patients, respectively. Median follow-
up was significantly longer in the Johanson group compared
to the Blandy group (36 versus 9 months; 𝑃 < 0.001).
Early postoperative complications were scored according to
the Clavien-Dindo classification [15]. Patients were further
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Table 1: Patient and stricture characteristics. Values are presented as mean ± standard deviation or number (%). For follow-up, the median
value with interquartile range is provided because of unequal variances.
Total (𝑛 = 51) Johanson (𝑛 = 35) Blandy (𝑛 = 16) 𝑃 value
Follow-up (months)
Mean (± standard deviation) 36.3 ± 41.6 47.9 ± 45.5 11.1 ± 10.4 0.002∗
Median (interquartile range) 16 (8–48) 36 (11–75) 9 (6–13) <0.001∗
Age (years) 60.1 ± 15.1 60.5 ± 14.7 59.2 ± 16.4 0.769∘
Stricture length (cm) 8.6 ± 5.0 9.3 ± 5.0 7.1 ± 4.8 0.141∘
Preop 𝑄max (mL/s) 3.1 ± 4.8 2.6 ± 3.1 3.9 ± 6.6 0.483
∘
Etiology
Idiopathic 8 (15.7%) 6 (17.1%) 2 (12.5%)
Iatrogenic 21 (41.2%) 17 (48.6%) 4 (25.0%)
Traumatic 5 (9.8%) 2 (5.7%) 3 (18.8%) 0.271§
Inflammatory 7 (13.7%) 5 (14.3%) 2 (12.5%)
Urethrectomy 10 (19.6%) 5 (14.3%) 5 (31.2%)
Previous interventions
None 13 (25.5%) 8 (22.96%) 5 (31.2%)
DVIU/dilation 7 (13.7%) 7 (20.0%) 0 (0.0%) 0.074§
Urethroplasty 31 (60.8%) 20 (57.1%) 11 (68.8%)
Location
Bulbar 12 (23.5%) 10 (28.6%) 2 (12.5%)
Penile 12 (23.5%) 7 (20.0%) 5 (31.2%)
Membranous 5 (9.8%) 1 (2.9%) 4 (25.0%) 0.053§
Panurethral 22 (43.1%) 17 (48.6%) 5 (31.2%)
Suprapubic catheter
No 35 (68.6%) 24 (68.6%) 11 (68.8%)
Yes 16 (31.4%) 11 (31.4%) 5 (31.2%) 0.99#
(∗Mann-Whitney test; ∘independent samples 𝑡-test; §Fisher’s exact test; #Chi-square test.)
followed up on a regular basis with history taking, clinical
examination, and uroflowmetry. In case of suspicion of steno-
sis, urethrography and ureteroscopy were performed. Need
for any additional urethral instrumentation (including dila-
tion) was defined as failure. In November 2013, all surviving
patients (𝑛 = 44) were sent the IPSS (International Prostate
Symptom Score). The IPSS is used to score obstructive and
irritative voiding symptoms with a score varying from 0 (no
symptoms) to 35 (very severe symptoms). It also contains
a question on quality of life (QoL) varying from 0 (very
satisfied) to 6 (very dissatisfied). We redistributed QoL score
into 3 groups: satisfactoryQoL (score 0 → 2), acceptableQoL
(score = 3), and dissatisfied with QoL (score 4 → 6). The
study was approved by the local ethics committee (EC UZG
2007/434 and EC UZG 2008/234).
2.2. Surgical Technique. Patients were placed in the lithotomy
position. For Blandy PU, an inverted-U perineal incision
was made. For the Johanson procedure, an inverted-U or
midline perineal incision was performed.The bulbar urethra
was exposed and opened ventrally. The urethrotomy was
extended proximally until healthy urethra was encountered.
For patients with stricture, at the membranous urethra, the
urethrotomy was extended into the membranous urethra
up to the apex of the prostate. In this series, a complete
transection of the urethra with mobilization of the proximal
urethral stump towards the perineum was never performed.
For Johanson PU, scrotal skin was invaginated towards
the opened urethra (Figure 1) and an incision was made
at the scrotal skin according to the length of the opened
urethra. The scrotal skin edges were sutured to the urethral
mucosa with interrupted sutures Vicryl 3.0. For an extensive
description and illustrations of this technique, we refer to
a previous publication [12]. For Blandy PU, the apex of the
inverted-U perineal flap was sutured to the most proximal
part of the opened urethra.The edges of the perineal flapwere
further sutured distally to the urethral mucosal edges with
Vicryl 3.0. From the moment tension occurred between the
sutures, a midline incision was made at the posterior scrotal
skin, and two scrotal skin flaps were mobilized to finalize the
PU (Figure 2).
2.3. Statistical Analysis. Groups were analyzed with inde-
pendent samples 𝑡-test (equal variances) or Mann-Whitney
test (unequal variances) for continuous variables and with
Chi-square or Fischer’s exact test for categorical variables.
One-year failure free survival (FFS) was evaluated using
Kaplan-Meier survival analysis and log-rank statistics. Logis-
tic regression analysis was performed to identify factors
predicting failure and QoL. For failure, analyzed factors were
patient’s age, stricture etiology, stricture length, stricture loca-
tion, previous interventions, type of operation, and presence
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(a) (b)
Figure 1: Technique of Johanson PU. After opening of the proximal urethra (a). Mobilisation of the scrotal skin to the proximal urethra (b).
(a) (b) (c) (d)
(e) (f) (g) (h)
Figure 2: Technique of Blandy PU. Inverted-U perineal incision (a). Exposure of the bulbar urethra (b). Opening of the bulbar urethra (c).
Hemostatic sutures on the corpus spongiosum and suturing of the tip of the inverted-U flap towards the proximal urethral opening (d).
Suturing of the inverted-U flap to the urethral edges (e). Creation of scrotal flaps (f) and advancement to the urethral mucosa (g). Closure of
the wound and final result (h).
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of a suprapubic catheter. For QoL, analyzed factors were
patient’s age, stricture etiology, and failure of PU. A 𝑃 value
<0.05 is considered as statistically significant.
3. Results and Discussion
Only 13 (25.5%) patients did not undergo previous urethral
interventions. Seven (13.7%) patients underwent at least one
urethrotomy and/or dilation. Thirty-one patients (60.8%)
underwent at least one previous urethroplasty (with or
without urethrotomy/dilation). Ten (19.6%) patients under-
went PU after urethrectomy: 3 patients because of urethral
malignancy and 7 patients concomitant with penectomy for
penile malignancy (𝑛 = 5) or penile gangrene (𝑛 = 2).
For the entire cohort, 11 (21.6%) patients suffered a failure.
In the Johanson group, 9 (25.7%) patients experienced failure
versus 2 (12.5%) patients in the Blandy group (𝑃 = 0.248)
(Table 2). One-year FFS was 86.5% for the entire cohort and
87.3 and 84.8% for the Johanson and Blandy groups, respec-
tively (log-rank 𝑃 = 0.904). The mean time to recurrence
was 29.7 months for the Johanson group and 5 months for
the Blandy group (𝑃 = 0.415). In the Johanson group, 3
and 2 failures were treated with VY-plasty and intermittent
urethrotomies/dilations, respectively. The remaining 4 fail-
ures were treated with a Blandy PU, mesh graft augmented
PU, buccal mucosa graft augmented PU, and a 7-flap perineal
urethrostomy. The failures in the Blandy group were treated
with a mesh graft augmented PU. Eight (15.7%) patients
suffered a postoperative complication, with 4 complications
reported in each group (Johanson 11.5% versus Blandy 25%;
𝑃 = 0.237). One patient developed urosepsis and was treated
with intravenous antibiotics (grade 2). Six patients suffered
wound dehiscence treated conservatively with secondary
healing in 4 patients (grade 1) and by surgical closure in 2
patients (grade 3b). One patient had a severe postoperative
bleeding and needed surgical exploration (grade 3b).The two
failures in the Blandy group suffered a postoperative wound
dehiscence with secondary healing and this was identified
as the cause of failure. For the other failures, no apparent
cause could be identified. Compared to the preoperative
situation, there was a significant improvement of maximum
urinary flow (𝑄max) (3.1 versus 13.0mL/s; 𝑃 < 0.001). This
improvement remained significant for both groups: from 2.6
to 10.9mL/s in the Johanson group and from 3.9 to 16mL/s
in the Blandy group.
Of 44 surviving patients, 32 (62.7%) patients sent back
the questionnaires (19 and 13 patients after Johanson and
Blandy PU, resp.). One patient treated with Johanson PU only
answered the QoL questionnaire. Mean postoperative IPSS
was 8.7 for the entire cohort. IPSS after Johanson and Blandy
PU was, respectively, 10.2 and 6.6 (𝑃 = 0.078). For the entire
cohort, 14 (43.7%), 12 (37.5%), and 6 (18.8%) patients reported,
respectively, a satisfactory, acceptable, and dissatisfactory
QoL after PU. Four dissatisfied patients had Johanson PU
(21.1%) and two had Blandy PU (15.4%). Differences in QoL
were not statistically significant between both groups (𝑃 =
0.635).
Logistic regression analysis could not identify any signif-
icant factors that predicted failure of PU (Table 3). Failure of
Table 2: Surgical and functional outcomes. Values are presented as
mean ± standard deviation or number (%).
Total Johanson Blandy 𝑃 value
Operation time
(min) 102.1 ± 37.3 97.2 ± 33.7 112.6 ± 43.4 0.172
∘
Failure
No 40 (78.4%) 26 (74.3%) 14 (87.5%) 0.248§
Yes 11 (21.6%) 9 (25.7%) 2 (12.5%)
Time to recurrence
(months) 31.6 ± 39 29.7 ± 39.2 5.0 ± 2.8 0.415
∘
Complications
No 43 (84.3%) 31 (88.6%) 12 (75.0%)
Grade 1 4 (7.8%) 1 (2.9%) 3 (18.8%) 0.237§
Grade 2 1 (2.0%) 1 (2.9%) 0 (0%)
Grade 3 3 (5.9%) 2 (5.7%) 1 (6.2%)
𝑛 = 26 𝑛 = 15 𝑛 = 11
Postop 𝑄max (mL/s) 13.0 ± 7.5 10.9 ± 6.3 16.0 ± 8.2 0.087
∘
𝑛 = 31 𝑛 = 18 𝑛 = 13
IPSS (0 → 35) 8.7 ± 5.6 10.2 ± 5.1 6.6 ± 5.8 0.078∘
Postvoid dribbling
Absent 23 (74.2%) 14 (77.8%) 9 (69.2%)
Present 8 (25.8%) 4 (22.2%) 4 (30.8%) 0.448§
𝑛 = 32 𝑛 = 19 𝑛 = 13
QoL
Satisfied (0 → 2) 14 (43.7%) 7 (36.8%) 7 (53.8%)
Acceptable (3) 12 (37.5%) 8 (42.1%) 4 (30.8%) 0.635§
Dissatisfied
(4 → 6) 6 (18.8%) 4 (21.1%) 2 (15.4%)
(∘Independent samples 𝑡-test; §Fisher’s exact test.)
Table 3: Univariate logistic regression analysis.
Predictive factor
for failure OR (95%-CI) 𝑃 value
Type of operation 0.179 (0.019–1.658) 0.13
Follow-up 1.007 (0.991–1.023) 0.405
Age 0.984 (0.937–1.034) 0.525
Stricture length 1.099 (0.945–1.279) 0.221
Etiology 0.957 (0.530–1.729) 0.885
Previous
interventions 0.653 (0.247–1.729) 0.391
Location 0.839 (0.549–2.091) 0.839
Suprapubic
catheter 0.243 (0.026–2.272) 0.215
PU tends to predict dissatisfaction with QoL (odds ratio 5.5;
95% CI 0.8–37.6; 𝑃 = 0.08).
PU is an option to manage complex and/or recurrent
urethral strictures [7, 12, 16] and is needed after urethrec-
tomy/penectomy [8, 9]. Nevertheless, success with PU is
far from guaranteed as shown by the 21.6% failure rate
in this series. This failure rate corresponds well to the 0–
30% failure rate reported by other series [7, 10, 11, 16, 17].
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Comparison between series is difficult because of differences
in follow-up and study population. Peterson et al. reported
100% success [16]. In this series, only 18% of cases underwent
prior urethroplasty and stricture etiologywas lichen sclerosus
which mainly affects the penile urethra. Therefore, PU could
be performed at a healthy, unaffected bulbar urethra. These
factors probably explain the favorable results in their series.
This is in contrast to our series and the series of Barbagli
et al. [7], Kulkarni et al. [17], and Myers et al. [11], where,
respectively, 60.8%, 52.6%, 96.3%, and 48% of patients under-
went one or more urethroplasties. Previous urethroplasty is a
well-known risk factor for failure in urethral reconstruction
[3, 5, 6]. Indeed, after previous urethroplasty, the urethra is
already scarred and of poorer quality and if this segment
needs to be used for PU, it can lead to further scarring and
narrowing of PU.This is certainly the case in our series where
only 23.5% of patients had no involvement of the bulbar
urethra, which is incorporated in the PU. This might explain
the higher failure rate in our series and the series of Barbagli et
al. [7], Kulkarni et al. [17], andMyers et al. [11] In this context,
it is important to inform the patient that recurrence after PU
is possible, despite the fact that it is offered as the final solution
for his complex/recurrent stricture.
Until 2009, Johanson PU was our preferred technique.
From 2010, we started with Blandy PU as preferred modality.
This has several reasons. (1) In 2009, two major series were
published on Blandy PU and currently Blandy PU is the
standard technique for PU. So, we started to follow the
mainstream in PU, which explains the significant shorter
follow-up time with Blandy PU. (2) The Johanson technique
has several inconveniences for the patient: the invagination of
the scrotal skin is unaesthetic and the patient urinates on the
scrotum (Figure 1). (3)We find the Blandy technique easier to
perform compared to the Johanson technique. This might be
contradictory as the operation time with Blandy technique
is longer compared to the Johanson technique. This longer
operation time may reflect the learning curve we had to
go through with the Blandy technique. Furthermore, during
Blandy PU technique, we sutured the edges of the opened
corpus spongiosum for hemostasis (Figure 2(d)), which was
not performed during Johanson PU. This was the reason for
one case of the severe postoperative bleeding in the Johanson
group. Because of the significant difference in follow-up for
the Johanson and Blandy groups, it is not possible to draw
conclusions about possible differences or equalities between
both techniques based on these data. However, Blandy PU
is now generally considered as the standard technique for
PU, and our data suggest that Johanson PU remains an
option, especially when Blandy PU is not possible. This is,
for instance, the case if the bulbar urethra is approached
by a midline perineal incision for urethroplasty and when
the peroperative findings make a one-stage reconstruction
impossible. In this case, a two-stage procedure or formal PU
must be performed. A Blandy PU is no longer possible, since
no inverted-U flap is available, but the Johanson technique is
still an option. An alternative for this case is a 7-flap perineal
urethrostomy [10]. Another case is when the inverted-U
flap of the Blandy technique cannot be brought towards the
proximal urethra without any tension (e.g., obese patients
or stricture extending in the proximal bulbar urethra or
membranous urethra). As the scrotal skin is very elastic, it can
usually be mobilized even up to the level of the membranous
urethra, and, for this case, the Johanson technique can
be performed. In our series, both failures in the Blandy
group were due to tension at the anastomosis between the
urethra and the inverted-U flap with wound dehiscence
and subsequent stenosis of the neomeatus. These failures
might have been prevented if another technique such as the
Johanson technique would have been used. Another option
would be to transect the urethra and mobilize the proximal
urethral stump towards the perineal incision. This was never
performed in this series. Particularly for membranous or
deep bulbar strictures, this maneuver will not lead to a
substantial gain of length in order to reduce tension with
perineal skin flaps. Furthermore, transection of the urethra
will eliminate the retrograde blood supply of the proximal
urethra. As the majority of patients in our series already
underwent previous urethroplasty, we opted to preserve the
urethral blood supply as much as possible to avoid ischemic
damage to the urethra at which the PU is performed.Myers et
al. [11] also postulated that preservation of the urethral blood
supply is an important key to success in PU.
In this series, 18.8% of patients were dissatisfied after PU
with no significant differences between the two groups.This is
higher compared to the 1.2% and 0%dissatisfaction rate in the
series of Barbagli et al. [7] andPeterson et al. [16], respectively.
Failure of PU tends to predict dissatisfaction. This might
explain our higher dissatisfaction rate compared to the series
of Peterson et al. [16] where no patients suffered a recurrence.
This, however, cannot explain the higher dissatisfaction rate
compared to the series of Barbagli et al. [7] with a similar
failure rate. For 3 out of 6 dissatisfied patients, there was a
specific reason in this series. In one patient, PU was the end
point of an iatrogenic stricture after transurethral resection
of the prostate. He considered this a serious complication of
what he expected to be a simple procedure for benign pro-
static hyperplasia [18].This patient wasmore dissatisfied with
the whole urologic history rather than with PU itself. Two
other dissatisfied patients underwent PU after penectomy. In
these patients, PU was not a choice but a necessity that was
suddenly needed. This is in contrast to patients who have a
long history of urethral stricture disease in which PU is often
a relief. Most of these patients in our series indeed underwent
several urethral manipulations (urethroplasty, urethrotomy,
and dilations) or had a suprapubic catheter. For these patients
it is a relief to be able to void again, even if this is in a
seated position. It is much more likely that these patients
will be more satisfied with PU compared to patients after
urethrectomy/penectomy who are “condemned” to PU.
This study has several important limitations. It concerns a
single-center and retrospective study.The follow-up duration
differs significantly between both groups and is on average
less than 1 year in the Blandy group. A comparison between
both groups is therefore subject to important bias and hard
conclusions cannot be made based on these data. With
longer follow-up, it is probable that more failures will be
detected in the Blandy group, further affecting surgical and
functional outcome. Evaluation of the functional outcome
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with questionnaires is hampered by 37% of patients who
did not return the questionnaire. It is impossible to estimate
whether or not more dissatisfied patients have not responded
to the invitation to fill in the questionnaire. IPSS is used to
score obstructive and irritative symptoms after PU. Although
IPSS is frequently used to describe voiding symptoms before
and after urethral reconstruction, it is not validated for this
pathology and Nuss et al. [19] reported that 21% of patients
with urethral stricture disease reported symptoms that were
not scored by IPSS. Validated questionnaires for urethral
reconstruction are recently developed [20] and should be
used in the future for further evaluation. Another limitation
is that there are no functional scores available before PUnor is
there a control group that remained on suprapubic diversion
or repetitive urethral manipulations.
4. Conclusion
About 1 out of 5 patients suffered a recurrence after PU and
the patient should be informed about this risk. Although
the majority of patients had a satisfactory/acceptable QoL
after PU, the dissatisfaction rate in this series is higher than
previously reported.
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